AbbVie Reports High Cure Rate for Acute Hepatitis C
October 11, 2026
Important Health - What Actually Matters
Health Policy
FDA finalizes guidance on written responses and meeting types
October 12, 2026
The FDA has finalized its guidance on written responses and meeting types, revising circumstances for INTERACT meetings under the Prescription...
READ THE ARTICLE 
AI agents help manage data surge in trials
October 10, 2026
Peptides face metabolic stability challenges
October 9, 2026
Medable AI Agent Promises $21M Value in Clinical Trials
October 8, 2026
RISK FACTORS
Cancer vaccine uses COVID immune memory
Celloram develops cancer vaccine using COVID immune memory to activate T cells against tumors in mice.
Apixaban Cuts Stroke Risk in Kidney Patients
Apixaban may cut stroke risk in kidney patients with atrial fibrillation and chronic kidney disease.
Medicaid plans may face behavioral health barriers, including workforce and data sharing issues, affecting care integration and support...
Vanderbilt informatics leader Peter Embí is named next NLM director, bringing decades of expertise in clinical research, AI,...
UNC researchers test doulas and alerts to improve Black maternal health outcomes in a major $10 million study...
Three healthcare programs use data to solve real problems in maternal, infant health and veteran care—proven innovations with...
All Post
FDA finalizes guidance on written responses and meeting types
The FDA has finalized its guidance on written responses and meeting types, revising circumstances for INTERACT meetings under the Prescription...
AbbVie Reports High Cure Rate for Acute Hepatitis C
AbbVie's Maviret achieved a 96% cure rate in a Phase 3 trial for acute hepatitis C, leading to U.S. approval...
AI agents help manage data surge in trials
Phase-3 clinical trials are generating unprecedented data volumes, a trend that fuels the vision of an autonomous clinical trial while...
Peptides face metabolic stability challenges
Peptides face metabolic stability challenges in treating diseases like obesity and cardiovascular disorders with peptide therapeutics.
Medable AI Agent Promises $21M Value in Clinical Trials
Medable's AI agent promises about $21M value in clinical trials, offering an 82x ROI for phase 3 studies.
Cancer vaccine uses COVID immune memory
Celloram develops cancer vaccine using COVID immune memory to activate T cells against tumors in mice.
Digital pathology enables virtual controls reduces animal testing
During the COVID-19 pandemic, the need for remote work pushed digital pathology from a niche tool to a core component...
New Drug Survodutide Shows Promise for Obesity, Diabetes
Survodutide shows promise as a treatment for obesity and diabetes, with significant weight loss and improved glycaemic control in trials.
Moving to Wealthier Areas Cuts Diabetes Risk
Research presented at the European Association for the Study of Diabetes meeting in Milan indicates that moving from a high-poverty...
South Goa Hospital Moves College Amid Bed Crunch
South Goa District Hospital is considering a temporary relocation of its nursing college to address critical space shortages for patients....